Michael A. Panzara
CIK 1679039 · Chief Medical Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$763.7K
Companies
4
Total Filings
24
Lifetime Open-Market Net
-$1.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LONA | Director | — | $7.50 | — | $0 | 2 | 2026-06-24 |
| IMUX | Chief Medical Officer | — | $14.10 | — | $0 | 1 | 2026-04-29 |
| LeonaBio, Inc. (ATHA) Delisted | Director | — | $6.92 | — | $0 | 5 | 2025-06-03 |
| WVE | See Remarks | 125,817 | $6.07 | $763.7K | -$1.68M | 16 | 2022-07-27 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-18 | WVE | Sell (S) | −10,603 | -$24.5K | EDGAR |
| 2022-01-04 | WVE | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | WVE | Mixed | +47,071 | -$31.0K | EDGAR |
| 2020-03-05 | WVE | Grant (A) | — | $0 | EDGAR |
| 2020-02-20 | WVE | Sell (S) | −2,981 | -$23.4K | EDGAR |
| 2019-07-09 | WVE | Sell (S) | −3,058 | -$82.4K | EDGAR |
| 2019-03-11 | WVE | Mixed | +8,000 | -$336.0K | EDGAR |
| 2019-02-21 | WVE | Sell (S) | −1,837 | -$67.7K | EDGAR |
| 2018-02-21 | WVE | Sell (S) | −511 | -$26.6K | EDGAR |
| 2018-02-20 | WVE | Mixed | — | -$530.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.